Literature DB >> 23349360

Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex.

David M Feliciano1, Shiliang Zhang, Jennifer L Quon, Angélique Bordey.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in TSC1 or TSC2 resulting in hyperactivity of the mammalian target of rapamycin and disabling brain lesions. These lesions contain misplaced neurons enriched in hypoxia-inducible factor 1a (HIF1a). However, the relationship between TSC1/2 and HIF1a and the function of HIF1a in TSC neurons remain unexplored. Here, we examine the degree of HIF1a activity and its function in newborn Tsc1(null) neurons in a mouse model of TSC. Using single cell electroporation in the neurogenic subventricular zone (SVZ) of neonatal mice, we deleted Tsc1 and generated olfactory lesions containing misplaced Tsc1(null) neurons as previously reported. These newborn neurons displayed elevated HIF1a-mediated transcriptional activity when compared with Tsc1 heterozygote neurons and a marked resistance to cell death induced by a HIF1a antagonist. Electroporation of Hif1a targeting short hairpin RNA (shRNA) or dominant negative HIF1a constructs resulted in 80-90% loss of Tsc1(null) newborn neurons although sparing SVZ stem cells. Consistent with this later finding, induction of Hif1a shRNA expression during synaptic integration thus bypassing neuron production also resulted in newborn neuron death. Collectively, these results suggest that HIF1a acts as a molecular determinant of newborn neuron survival and that its TSC1-dependent up-regulation gave Tsc1(null) neurons a survival advantage, despite their misplacement in a novel microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349360      PMCID: PMC3613161          DOI: 10.1093/hmg/ddt018

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion.

Authors:  David M Feliciano; Jennifer L Quon; Tiffany Su; M Morgan Taylor; Angélique Bordey
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

2.  Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.

Authors:  Dehe Kong; Eun Jung Park; Andrew G Stephen; Maura Calvani; John H Cardellina; Anne Monks; Robert J Fisher; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.

Authors:  Robert P Carson; Dominic L Van Nielen; Peggy A Winzenburger; Kevin C Ess
Journal:  Neurobiol Dis       Date:  2011-08-26       Impact factor: 5.996

4.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Authors:  Andrew Y Choo; Sang Gyun Kim; Matthew G Vander Heiden; Sarah J Mahoney; Hieu Vu; Sang-Oh Yoon; Lewis C Cantley; John Blenis
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

5.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Bo Zhang; David H Gutmann; Michael J Gambello; Michael Wong
Journal:  Hum Mol Genet       Date:  2010-11-09       Impact factor: 6.150

6.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

7.  Imaging and recording subventricular zone progenitor cells in live tissue of postnatal mice.

Authors:  Benjamin Lacar; Stephanie Z Young; Jean-Claude Platel; Angélique Bordey
Journal:  Front Neurosci       Date:  2010-07-19       Impact factor: 4.677

8.  mTOR cascade activation distinguishes tubers from focal cortical dysplasia.

Authors:  Marianna Baybis; Jia Yu; Allana Lee; Jeff A Golden; Howard Weiner; Guy McKhann; Eleonora Aronica; Peter B Crino
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  Olfactory hamartomas in tuberous sclerosis.

Authors:  G A de León; N Zaeri; C M Foley
Journal:  J Neurol Sci       Date:  1988-11       Impact factor: 3.181

10.  TSC2 regulates VEGF through mTOR-dependent and -independent pathways.

Authors:  James B Brugarolas; Francisca Vazquez; Archana Reddy; William R Sellers; William G Kaelin
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

View more
  5 in total

1.  Hypoxia-inducible factor-1a contributes to dendritic overgrowth in tuberous sclerosis.

Authors:  Longbo Zhang; David M Feliciano; Tianxiang Huang; Shiliang Zhang; Angélique Bordey
Journal:  Neurosci Lett       Date:  2015-12-02       Impact factor: 3.046

2.  Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.

Authors:  Longbo Zhang; Tianxiang Huang; Shannon Teaw; Angélique Bordey
Journal:  Epilepsia       Date:  2019-05-24       Impact factor: 5.864

3.  Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells.

Authors:  Irina Korshunova; Sina Rhein; Diego García-González; Ines Stölting; Ulrich Pfisterer; Anna Barta; Oksana Dmytriyeva; Agnete Kirkeby; Markus Schwaninger; Konstantin Khodosevich
Journal:  JCI Insight       Date:  2020-02-27

Review 4.  Neuronal survival in the brain: neuron type-specific mechanisms.

Authors:  Ulrich Pfisterer; Konstantin Khodosevich
Journal:  Cell Death Dis       Date:  2017-03-02       Impact factor: 8.469

5.  Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.

Authors:  Anna R Malik; Ewa Liszewska; Agnieszka Skalecka; Malgorzata Urbanska; Anand M Iyer; Lukasz J Swiech; Malgorzata Perycz; Kamil Parobczak; Patrycja Pietruszka; Malgorzata M Zarebska; Matylda Macias; Katarzyna Kotulska; Julita Borkowska; Wieslawa Grajkowska; Magdalena E Tyburczy; Sergiusz Jozwiak; David J Kwiatkowski; Eleonora Aronica; Jacek Jaworski
Journal:  Acta Neuropathol Commun       Date:  2015-07-30       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.